These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39289136)

  • 1. The immunology underlying CNS autoantibody diseases.
    Cleaver J; Ceronie B; Strippel C; Handel A; Irani SR
    Rev Neurol (Paris); 2024 Nov; 180(9):916-930. PubMed ID: 39289136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies associated with diseases of the CNS: new developments and future challenges.
    Vincent A; Bien CG; Irani SR; Waters P
    Lancet Neurol; 2011 Aug; 10(8):759-72. PubMed ID: 21777830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy.
    Varley J; Taylor J; Irani SR
    Neuropharmacology; 2018 Apr; 132():71-82. PubMed ID: 28476644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The B cell immunobiology that underlies CNS autoantibody-mediated diseases.
    Sun B; Ramberger M; O'Connor KC; Bashford-Rogers RJM; Irani SR
    Nat Rev Neurol; 2020 Sep; 16(9):481-492. PubMed ID: 32724223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the future of autoimmune encephalitides.
    Guasp M; Dalmau J
    Rev Neurol (Paris); 2024 Nov; 180(9):862-875. PubMed ID: 39277478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the laboratory in the expanding field of neuroimmunology: Autoantibodies to neural targets.
    Naides SJ
    J Immunol Methods; 2018 Dec; 463():1-20. PubMed ID: 30300607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updating Neuroimmune Targets in Central Nervous System Dysfunction.
    Valente LA; Begg LR; Filiano AJ
    Trends Pharmacol Sci; 2019 Jul; 40(7):482-494. PubMed ID: 31130220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune-mediated epilepsy and encephalopathy].
    Kramme C; Bien CG
    Nervenarzt; 2013 Apr; 84(4):442-9. PubMed ID: 23334452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune encephalitis: recent clinical and biological advances.
    Varley JA; Strippel C; Handel A; Irani SR
    J Neurol; 2023 Aug; 270(8):4118-4131. PubMed ID: 37115360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody-mediated disorders of the central nervous system.
    Irani S; Lang B
    Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Therapeutic Approach to Autoimmune Neurologic Disorders.
    López-Chiriboga AS; Flanagan EP
    Semin Neurol; 2018 Jun; 38(3):392-402. PubMed ID: 30011418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric antigen receptor T-cell therapy for autoimmune diseases of the central nervous system: a systematic literature review.
    Konitsioti AM; Prüss H; Laurent S; Fink GR; Heesen C; Warnke C
    J Neurol; 2024 Oct; 271(10):6526-6542. PubMed ID: 39276207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system.
    Sinmaz N; Nguyen T; Tea F; Dale RC; Brilot F
    J Neuroinflammation; 2016 Aug; 13(1):219. PubMed ID: 27577085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders.
    Damato V; Balint B; Kienzler AK; Irani SR
    Mov Disord; 2018 Sep; 33(9):1376-1389. PubMed ID: 30218501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Sclerosis and Autoimmune Neurology of the Central Nervous System.
    Galetta KM; Bhattacharyya S
    Med Clin North Am; 2019 Mar; 103(2):325-336. PubMed ID: 30704684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune-mediated encephalomyelitis].
    Wildemann B; Bien CG
    Nervenarzt; 2013 Apr; 84(4):435. PubMed ID: 23525588
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.
    Flach AC; Litke T; Strauss J; Haberl M; Gómez CC; Reindl M; Saiz A; Fehling HJ; Wienands J; Odoardi F; Lühder F; Flügel A
    Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3323-8. PubMed ID: 26957602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Encephalitis.
    Irani SR
    Continuum (Minneap Minn); 2024 Aug; 30(4):995-1020. PubMed ID: 39088286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune-associated seizure disorders.
    Smith KM; Budhram A; Geis C; McKeon A; Steriade C; Stredny CM; Titulaer MJ; Britton JW
    Epileptic Disord; 2024 Aug; 26(4):415-434. PubMed ID: 38818801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune dementia and encephalopathy.
    Flanagan EP; Drubach DA; Boeve BF
    Handb Clin Neurol; 2016; 133():247-67. PubMed ID: 27112681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.